A different approach to healthcare VC.
Introducing Grand Rounds Capital.
Early-stage venture fund investing catalytic capital into medical technology from America's heartland.
Overindexing clinician support, underindexing coastal pedigree, and seeking sector-defining clinical impact.
What are "Grand Rounds"?
Grand Rounds are a component of medical education where a real case is laid in front of the people who actually treat patients and examined honestly, in full, with the newest evidence on the table. No marketing. No slick sales reps. Just the patient, the problem, and the question of what genuinely helps.We take our name from this practice because it is core to our investment philosophy. We believe clinicians should be the vanguard of healthcare's future, not simply an afterthought brought in to validate a pitch written consultants and MBAs.The best medical device companies are not built by the people closest to capital. They are built by the people closest to the patient. Our job is to put those two things in the same room and then clear any blockers out of the way.
Capital is in the Wrong Place
Medical device innovation is systematically underfinanced outside of the coasts; not because the talent isn't there, but because the capital isn't.The Midwest sits at the intersection of three things that almost never coexist: elite clinical institutions, a deep and experienced device manufacturing base, and the enterprise health system customers who ultimately decide whether a technology lives or dies. The entire value chain of a medical device company, concentrated in one region, waved away in a derogatory comment about "flyover country."This isn’t just a market inefficiency; this is a mind-blowing market failure.
There is tremendous opportunity when you know where to look.
Being in the American Heartland is necessary. It is not sufficient.
Our real edge is the depth of our ownership, the density of our regional relationships, and our willingness to stand behind founders through the things that scare other money away; regulatory headwinds, reimbursement cycles, and the long product development timelines that define medical technology.We back companies with a clear clinical champion, a credible regulatory pathway, and a chip on their shoulder about how much harder they have had to work to be taken seriously. That chip is not a personality flaw. For us, it's a leading indicator.Medical technology is a marathon, not a sprint. You do not change the healthcare world overnight, and you certainly don’t do it with a chatbot subscription and bunch of tokens . We are not here for a quick buck or a passive bet. We aim to be the first institutional check and a true partner-champion from day one to exit: in the room for the FDA strategy, the first hospital contract, and inevitable sucker punch nobody warned you about.
Redefining the future of medicine.
Whether you're a clinician building the next billion-dollar surgical robot or you are just interested in learning more about what we are working on, we welcome the opportunity to stay in touch.